| 摘要 |
Adenine nucleotides such as adenosine 5'-monophosphate (AMP), adenosine 5'-diphosphate (ADP) or adenosine 5'-triphosphate (ATP) and/or adenosine and inorganic phosphate are administered in the treatment of advanced cancer in an out-patient setting and without serious side effects. Administration of up to 100 micrograms/kilogram/minute of continuous intravenous infusions of ATP for 8-10 hours, can be performed on an out-patient basis to patients who do not otherwise require hospitalization. No serious side effects, defined as grades 3 or 4 toxicity are observed during such an infusion. |
